Entropy theory states that things would rather exist in a state of chaos or lack of order. Much like the company’s name, the career progression and professional experiences of its founder have been anything but orderly. Her unique and rare combination skill set is the foundation upon which Entropia was created.

Dr. Qualls is a trained scientist and astute business professional with a history of driving needed change in both corporate and nonprofit environments. She is an organic chemist turned strategist with over 15 years of research training in the chemical sciences and nearly 20 years of leadership experience in the US and abroad. Her experience spans from the bench to the boardroom.

Dr. Qualls has conducted and published chemical and biomedical research at Purdue University and has developed strategy at GlaxoSmithKline, one of the leading pharmaceutical companies in the world. At GSK, she held roles of increased international responsibility spanning drug development, technology evaluation, business process improvement, program management and capital planning via facilities and scientific strategy development.

A high level strategist and big picture thinker whose talent transcends the rapidly evolving pharma landscape, Dr. Qualls possess all the attributes of a scientist yet commands a solid understanding of today’s business environment. She is consistently recognized for a skillful ability to simplify highly technical or complex concepts to bottom line terminology.

Dr. Qualls has a passion for developing a pipeline of those entering in STEM (Science, Technology, Engineering and Mathematics) fields. She devotes time to developing relationships with leaders of the chemical enterprise, professional organizations, academic departments or universities, and governmental agencies that have an interest in ensuring a diverse representation in the nation’s technical workforce. She delivers motivational speeches about her chosen career path and has served on numerous panels and focus groups discussing strategies on building and sustaining the STEM pipeline. She has developed an extensive network of relationships with leaders of the chemical enterprise, professional organizations, academic departments and governmental agencies and is a respected member of several leading technical professional organizations.